Related Experiment Video
Updated: Jun 5, 2026

Using Chicken Embryo as a Powerful Tool in Assessment of Developmental Cardiotoxicities
Published on: March 21, 2021
Single Antenatal Exposure to Ciclesonide Reduces Long-Term Cardiac Structural and Functional Alterations Compared to
Shekhar Gugnani1, Tooba Fida1, Rachel Tao1
1University of Missouri-Kansas City.
None:
Synthetic corticosteroids (sCS), Dexamethasone (Dex) or Betamethasone (Beta) are administered to mothers at risk of preterm birth to promote fetal organ maturation and reduce neonatal morbidity. Repeated prenatal or postnatal sCS exposure is associated with long term negative cardiovascular and neurologic outcomes. We previously demonstrated that repeated postnatal exposure to Ciclesonide (Cic) promotes lung maturation and minimizes birthweight or white matter reductions observed with repeated Dex administration. The long-term cardiac effects of a single antenatal sCS exposure are poorly understood. This study demonstrates that a single prenatal exposure to sCS reduces birth weight in a graded manner, with Dex>Beta > Cic. In aged animals Dex exposure led to an increase in body weight, Beta showed a trend towards a decrease, while Cic was indistinguishable from controls. Structural, histological, and electrophysiological cardiac abnormalities consistent with bradycardia and QTc prolongation were exclusively observed in aged Dex-exposed animals. Adult cardiac ion channel expression was decreased with Dex>Beta > Cic, indicating that the antenatal environment plays a pivotal role in short-term and long-term cardiac reprogramming. A single antenatal exposure to Cic minimizes adverse cardiometabolic effects compared to Dex or Beta suggesting that Cic may be a safer alternative for preterm birth compared to the current sCS clinical regimen.
More Related Videos
09:50Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
COPD: Management Using Bronchodilators and Corticosteroids